Skip to main navigation Skip to search Skip to main content

Doravirine Cerebrospinal Fluid (CSF) Pharmacokinetics in HIV-Infected Individuals

Project: Research

Project Details

StatusFinished
Effective start/end date06/4/19 → 12/31/25

Funding

  • Merck Sharp and Dohme Limited Liability Corporation: $242,646.38